康泰生物全資子公司獲得藥品注冊證
作者:
2018-05-14 17:44來源:中國證券報·中證網
中證網訊 康泰生物(300601)5月14日晚間公告,近日,公司全資子公司北京民海生物科技有限公司獲得科特迪瓦共和國(以下簡稱“科特迪瓦”)頒發的藥品注冊證,注冊產品為23價肺炎球菌多糖疫苗。
公司稱,本次獲得科特迪瓦藥品注冊證書,是23價肺炎球菌多糖疫苗取得科特迪瓦GMP證書后的又一里程碑式進展,有利于提高公司知名度和影響力,對公司國際市場的開拓產生積極影響,符合公司“走出去”的發展戰略。(孫萍)
中(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)(zheng)網(wang)(wang)(wang)聲明(ming)(ming):凡本網(wang)(wang)(wang)注明(ming)(ming)“來源(yuan):中(zhong)(zhong)(zhong)國證(zheng)(zheng)(zheng)(zheng)(zheng)券(quan)報(bao)·中(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)(zheng)網(wang)(wang)(wang)”的所有作(zuo)品(pin),版權均屬于中(zhong)(zhong)(zhong)國證(zheng)(zheng)(zheng)(zheng)(zheng)券(quan)報(bao)、中(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)(zheng)網(wang)(wang)(wang)。中(zhong)(zhong)(zhong)國證(zheng)(zheng)(zheng)(zheng)(zheng)券(quan)報(bao)·中(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)(zheng)網(wang)(wang)(wang)與作(zuo)品(pin)作(zuo)者(zhe)(zhe)聯合聲明(ming)(ming),任何(he)組(zu)織未經中(zhong)(zhong)(zhong)國證(zheng)(zheng)(zheng)(zheng)(zheng)券(quan)報(bao)、中(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)(zheng)網(wang)(wang)(wang)以及(ji)作(zuo)者(zhe)(zhe)書面授權不(bu)得轉載、摘編或利(li)用(yong)其它方(fang)式使用(yong)上述作(zuo)品(pin)。凡本網(wang)(wang)(wang)注明(ming)(ming)來源(yuan)非中(zhong)(zhong)(zhong)國證(zheng)(zheng)(zheng)(zheng)(zheng)券(quan)報(bao)·中(zhong)(zhong)(zhong)證(zheng)(zheng)(zheng)(zheng)(zheng)網(wang)(wang)(wang)的作(zuo)品(pin),均轉載自其它媒(mei)體,轉載目(mu)的在于更好服務讀者(zhe)(zhe)、傳(chuan)遞信息之需,并不(bu)代表本網(wang)(wang)(wang)贊同其觀點,本網(wang)(wang)(wang)亦不(bu)對其真實性負(fu)責,持異議者(zhe)(zhe)應與原出(chu)處單位主(zhu)張權利(li)。